David Stone 11/25/21 David Stone 11/25/21

New Covid-19 Variant B.1.1.529 (Omicron) Emerges in Africa

David Stone 11/23/21 David Stone 11/23/21

Gilead and the NIH Appear to be Holding Back Data on LNC Remdesivir

David Stone 10/1/21 David Stone 10/1/21

Merck’s Covid Pill Reduces Hospitalization by About 50%

David Stone 9/22/21 David Stone 9/22/21

Early Use of Remdesivir Reduces Hospitalization by 87%

David Stone 9/17/21 David Stone 9/17/21

The Market Potential of Oral Remdesivir

David Stone 4/13/21 David Stone 4/13/21

Is Gilead Holding Back Data on Inhaled Remdesivir?

David Stone 1/20/21 David Stone 1/20/21

Gilead Set to Soar as South African COVID-19 Strain Might Resist Vaccines

David Stone 12/20/20 David Stone 12/20/20

It Looks Like Gilead is About to Merge with Roche